Eva
Pérez Pampín
Iuliu Hațieganu University of Medicine and Pharmacy
Cluj, RumaníaPublications in collaboration with researchers from Iuliu Hațieganu University of Medicine and Pharmacy (6)
2021
-
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts
Frontiers in Immunology, Vol. 12
2020
2019
-
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)
Pharmacogenomics Journal
-
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96
2015
-
Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: A two-stage case-control study
Pharmacogenetics and Genomics, Vol. 25, Núm. 9, pp. 432-443
-
Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: A multicenter study
Pharmacogenetics and Genomics, Vol. 25, Núm. 7, pp. 323-333